CAJ | 학술논문

目的探讨既消除胸水、治疗胸膜病变，又切除或控制原发病灶的方法。方法对40例肺癌伴恶性胸水者行手术、免疫、介入或化疗。结果所有病人胸水消失，29例死于术后6～31个月(平均13个月)，9例术后5～52个月仍生存。结论外科综合治疗肺癌伴恶性胸水效果显著。
목적탐토기소제흉수、치료흉막병변，우절제혹공제원발병조적방법。방법대40례폐암반악성흉수자행수술、면역、개입혹화료。결과소유병인흉수소실，29례사우술후6～31개월(평균13개월)，9례술후5～52개월잉생존。결론외과종합치료폐암반악성흉수효과현저。
Objective　For the purposes of eliminating pleural effusions and treating pleural diseases meanwhile removing or controlling primary lung lesions.Methods　Forty lung cancer patients with malignant pleural effusion were undergone serial therapy of operations,immunotherapy, intervention chemotherapy or chemotherapy.Results　There were no operative deaths.The malignant pleural effusions were controlled after the therapy.Patients' general conditions were significantly improved.The mean survival time was 13 months(range,6 to 31 months).9 patients were still alive 5 to 52 months postoperatively.Conclusion　The therapy sequence of operation(including VATS, chest drain),immunotherapy, intervention chemotherapy or chemotherapy has offered one of the best therapy choices for lung cancer with malignant pleural effusion at present.